Ed Nice obtained his Licentiate from the Royal Institute of Chemistry in London in Advanced Analytical Chemistry in 1972 and Fellowship of the Chemical Society London in 1973. He is currently Adjunct Professor at Monash University where he is Head of the Clinical Biomarker Discovery and Validation (Department of Biochemistry and Molecular Biology) and a scientific advisor to the Monash Antibody Technologies Facility (MATF), of which he was Director from 2009 - 2013. He holds a Visiting Professorship at Sichuan University’s West China Hospital and an Adjunct position at Macquarie University. Ed’s long-term research interests have been in biomarker discovery and validation, high throughput monoclonal antibody production and validation and clinical biomarker assay development, with a strong translational focus on colorectal cancer.  He has an established international reputation in the fields of HPLC, SPR biosensor analysis and proteomics, and has made significant contributions in protein and peptide micropurification. More recently he has been involved in the development of layer-by-layer nanoparticles for drug delivery using proteomic technologies.

Colorectal Cancer, Biomarkers, Proteomics, Micropreparative HPLC, High THroughput Monoclonal Antibody Production, SPR, Personalised Medicine